DHTKD1

UniProt ID: Q96HY7
Organism: Homo sapiens
Review Status: INITIALIZED
📝 Provide Detailed Feedback

Gene Description

DHTKD1 is the E1 component (E1a; 2-oxoadipate dehydrogenase, OADH-E1) of the mitochondrial 2-oxoadipate dehydrogenase complex (OADHC). It is a thiamine diphosphate (ThDP)-dependent decarboxylase and a paralog of OGDH, the 2-oxoglutarate dehydrogenase E1. DHTKD1 catalyzes the first, rate-limiting and irreversible step of the complex: the oxidative decarboxylation of 2-oxoadipate (alpha-ketoadipate), transferring the decarboxylated glutaryl intermediate onto the lipoyl group of the shared E2 subunit (DLST), with the overall complex producing glutaryl-CoA and CO2. OADHC uses the same E2 (DLST) and E3 (DLD) components as the TCA-cycle 2-oxoglutarate dehydrogenase complex, but the E1 subunit is complex-specific; DHTKD1 strongly prefers 2-oxoadipate over 2-oxoglutarate as substrate. This reaction is the final common step of L-lysine, L-hydroxylysine and L-tryptophan degradation, whose convergent intermediate is 2-oxoadipate. The enzyme functions as a homodimer in the mitochondrial matrix. Loss-of-function variants cause alpha-aminoadipic and alpha-ketoadipic aciduria (AAKAD, frequently benign), and DHTKD1 has also been linked to axonal Charcot-Marie-Tooth disease type 2Q.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0005739 mitochondrion
IEA
GO_REF:0000044
ACCEPT
Summary: Subcellular-location IEA placing DHTKD1 in the mitochondrion, consistent with all experimental evidence and the mitochondrial transit peptide. Correct but less precise than the mitochondrial matrix localization supported by Reactome/Ensembl orthology.
Reason: DHTKD1 is a validated mitochondrial matrix enzyme (UniProt SUBCELLULAR LOCATION, PMID:23141294). The generic mitochondrion term is correct.
Supporting Evidence:
PMID:23141294
implicating an important role for DHTKD1 in mitochondrial energy production and neurological development.
GO:0016624 oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor
IEA
GO_REF:0000120
MARK AS OVER ANNOTATED
Summary: Broad InterPro/orthology-based oxidoreductase term describing the overall E1+E2+E3 (disulfide-acceptor) chemistry of the 2-oxo-acid dehydrogenase family. The precise activity of the E1a subunit is the ThDP-dependent decarboxylation captured by GO:0160166.
Reason: This family-level term describes the full dehydrogenase complex reaction in which the ultimate electron acceptor is a disulfide (lipoyl/E3). The DHTKD1 E1a subunit itself performs ThDP-dependent decarboxylation of 2-oxoadipate and transfers the acyl group to the E2 lipoyl moiety; the more specific and accurate MF for DHTKD1 is GO:0160166 (2-oxoadipate dehydrogenase activity), which is separately annotated with IDA support.
Supporting Evidence:
PMID:29191460
It is involved in the oxidative decarboxylation of 2-oxoadipate (OA) to glutaryl-CoA on the final degradative pathway of L-lysine
GO:0030976 thiamine pyrophosphate binding
IEA
GO_REF:0000002
ACCEPT
Summary: InterPro-based annotation of thiamine diphosphate (ThDP) binding. ThDP is the essential catalytic cofactor of DHTKD1, confirmed biochemically and by crystal structures of the DHTKD1-ThDP complex.
Reason: DHTKD1 is a ThDP-dependent decarboxylase; ThDP is documented as its cofactor (UniProt COFACTOR, PMID:32695416; DHTKD1-ThDP crystal structure PMID:32633484). The InterPro TPP-binding domain (IPR011603/IPR029061) is present. This is a core molecular function.
Supporting Evidence:
PMID:29191460
Herein are reported unique properties of the novel human thiamin diphosphate (ThDP)-dependent enzyme 2-oxoadipate dehydrogenase (hE1a)
GO:0160166 2-oxoadipate dehydrogenase activity
IEA
GO_REF:0000116
ACCEPT
Summary: RHEA-mapped IEA for the core catalytic activity of DHTKD1: the ThDP-dependent oxidative decarboxylation of 2-oxoadipate (RHEA:69576). This is the primary, experimentally validated molecular function.
Reason: Matches the reaction assigned in UniProt (RHEA:69576) and is directly supported by biochemistry (PMID:29191460, PMID:32633484) and structure. Duplicate of the IDA-supported GO:0160166 below; both are correct.
Supporting Evidence:
PMID:29191460
hE1a displays an approximately 49-fold preference in catalytic efficiency for OA over OG, indicating that hE1a is specific to the 2-oxoadipate dehydrogenase complex
GO:0005515 protein binding
IPI
PMID:28514442
Architecture of the human interactome defines protein commun...
MARK AS OVER ANNOTATED
Summary: High-throughput affinity-purification/mass-spectrometry interactome (BioPlex 2.0) IPI to PGLYRP3 (Q96LB9). Bare "protein binding" is uninformative about DHTKD1's molecular function.
Reason: This is a proteome-scale AP-MS screen, not a directed study of DHTKD1's biology; the recorded partner (PGLYRP3) has no established functional relationship to 2-oxoadipate catabolism. Per curation guidance, bare GO:0005515 protein binding IPIs are uninformative and are marked as over-annotation rather than removed. The biologically meaningful interaction of DHTKD1 is with the E2 subunit DLST, captured by the oxoadipate dehydrogenase complex annotation.
Supporting Evidence:
PMID:28514442
BioPlex 2.0 exceeds previous experimentally derived interaction networks in depth and breadth
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
MARK AS OVER ANNOTATED
Summary: Binary yeast-two-hybrid interactome (HuRI) IPI to an isoform of BMAL1 (O00327-8). Bare "protein binding" is uninformative about DHTKD1's molecular function.
Reason: This is a genome-scale binary interaction map, not a directed functional study of DHTKD1. The reported partner has no established role in 2-oxoadipate/lysine catabolism. Per curation guidance, bare protein binding IPIs are marked as over-annotation rather than removed.
Supporting Evidence:
PMID:32296183
A reference map of the human binary protein interactome.
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
MARK AS OVER ANNOTATED
Summary: High-throughput AP-MS interactome (BioPlex-derived, cell-specific networks) IPI to PGLYRP3 (Q96LB9). Bare "protein binding" is uninformative about DHTKD1's molecular function.
Reason: Proteome-scale interactome dataset rather than a directed DHTKD1 study; the reported partner has no established connection to 2-oxoadipate catabolism. Per curation guidance, bare protein binding IPIs are marked as over-annotation rather than removed.
Supporting Evidence:
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
GO:0005759 mitochondrial matrix
IEA
GO_REF:0000107
ACCEPT
Summary: Orthology-based (Ensembl Compara) is_active_in annotation to the mitochondrial matrix, transferred from mouse ortholog. Consistent with the matrix localization of a soluble ThDP-dependent dehydrogenase.
Reason: DHTKD1 has an N-terminal mitochondrial transit peptide and functions as a soluble matrix enzyme of the OADHC; matrix localization is supported by Reactome and by the shared architecture with the OGDH complex.
Supporting Evidence:
PMID:29191460
the dihydrolipoyl succinyltransferase (hE2o) and the dihydrolipoyl dehydrogenase (hE3) components of the tricarboxylic acid cycle 2-oxoglutarate dehydrogenase complex (OGDHc) for its activity
GO:0009063 amino acid catabolic process
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Orthology-based involvement in amino acid catabolism. Correct but a generic parent of the specific L-lysine/L-tryptophan catabolic processes DHTKD1 participates in.
Reason: Accurate at a high level (DHTKD1 acts on the convergent 2-oxoadipate step of lysine/hydroxylysine/tryptophan degradation) but subsumed by the more specific L-lysine catabolic process (GO:0019477). Retained as non-core background rather than as a distinct core function.
Supporting Evidence:
PMID:29191460
on the final degradative pathway of L-lysine and is critical for mitochondrial metabolism
GO:0019477 L-lysine catabolic process
IEA
GO_REF:0000107
ACCEPT
Summary: Orthology-based annotation to L-lysine catabolism. This is the principal biological process in which DHTKD1 acts, catalyzing the final common 2-oxoadipate step of the lysine (and hydroxylysine/tryptophan) degradation pathway.
Reason: Well supported: DHTKD1 performs the rate-limiting decarboxylation of 2-oxoadipate, the convergent intermediate of L-lysine catabolism; disease variants cause elevated 2-oxoadipate/2-aminoadipate. Core process.
Supporting Evidence:
PMID:29191460
It is involved in the oxidative decarboxylation of 2-oxoadipate (OA) to glutaryl-CoA on the final degradative pathway of L-lysine
GO:0005739 mitochondrion
IDA
GO_REF:0000052
ACCEPT
Summary: Immunofluorescence-based (HPA) IDA localizing DHTKD1 to the mitochondrion. Consistent with all other evidence.
Reason: Directly observed mitochondrial localization by immunofluorescence, concordant with the mitochondrial matrix function of the OADHC E1a subunit.
Supporting Evidence:
PMID:23141294
implicating an important role for DHTKD1 in mitochondrial energy production and neurological development.
GO:0005739 mitochondrion
HTP
PMID:34800366
Quantitative high-confidence human mitochondrial proteome an...
ACCEPT
Summary: High-throughput mitochondrial proteomics (MitoCoP) detecting DHTKD1 in the high-confidence human mitochondrial proteome.
Reason: Independent proteomic confirmation of mitochondrial localization, consistent with the transit peptide and matrix function.
Supporting Evidence:
PMID:34800366
defined a mitochondrial high-confidence proteome of >1,100 proteins (MitoCoP)
GO:0160166 2-oxoadipate dehydrogenase activity
IDA
PMID:29191460
The mitochondrial 2-oxoadipate and 2-oxoglutarate dehydrogen...
ACCEPT
Summary: Direct biochemical demonstration that recombinant human E1a (DHTKD1) oxidatively decarboxylates 2-oxoadipate, with ~49-fold catalytic preference for 2-oxoadipate over 2-oxoglutarate. This is the defining, experimentally validated molecular function of the gene.
Reason: Gold-standard IDA evidence for the core catalytic activity; corroborated by kinetics (KM 0.012-0.015 mM for 2-oxoadipate) and crystal structures (PMID:32633484, PMID:32695416).
Supporting Evidence:
PMID:29191460
hE1a displays an approximately 49-fold preference in catalytic efficiency for OA over OG, indicating that hE1a is specific to the 2-oxoadipate dehydrogenase complex
GO:0160167 oxoadipate dehydrogenase complex
IDA
PMID:29191460
The mitochondrial 2-oxoadipate and 2-oxoglutarate dehydrogen...
ACCEPT
Summary: DHTKD1 is the E1a subunit of the 2-oxoadipate dehydrogenase complex, which it forms together with the shared E2 (DLST) and E3 (DLD) components of the 2-oxoglutarate dehydrogenase machinery. Directly demonstrated by reconstitution of an active complex.
Reason: Core cellular-component annotation. DHTKD1 recruits E2 (DLST) and E3 (DLD) to assemble a functional OADHC; the E1 subunit is complex-specific. This is the biologically meaningful protein-protein assembly for DHTKD1.
Supporting Evidence:
PMID:29191460
The hE1a has recruited the dihydrolipoyl succinyltransferase (hE2o) and the dihydrolipoyl dehydrogenase (hE3) components of the tricarboxylic acid cycle 2-oxoglutarate dehydrogenase complex (OGDHc) for its activity
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-9858321
ACCEPT
Summary: Reactome TAS localizing the DHTKD1-catalyzed 2-oxoadipate decarboxylation to the mitochondrial matrix, the compartment of the OADHC.
Reason: Consistent with the soluble matrix location of the E1a subunit of the OADHC and with orthology/proteomic evidence.
Supporting Evidence:
PMID:29191460
the tricarboxylic acid cycle 2-oxoglutarate dehydrogenase complex (OGDHc) for its activity
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-9858589
ACCEPT
Summary: Reactome TAS localizing the OADHC E3 (DLD) dihydrolipoyl dehydrogenation step to the mitochondrial matrix, the compartment where DHTKD1 acts.
Reason: Matrix localization is well established for the OADHC in which DHTKD1 is the E1 subunit.
Supporting Evidence:
PMID:29191460
the dihydrolipoyl dehydrogenase (hE3) components of the tricarboxylic acid cycle 2-oxoglutarate dehydrogenase complex (OGDHc) for its activity
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-9858590
ACCEPT
Summary: Reactome TAS localizing the OADHC E2 (DLST) glutaryl transfer to CoA in the mitochondrial matrix, the compartment where DHTKD1 acts.
Reason: Consistent with matrix localization of the OADHC and of DHTKD1.
Supporting Evidence:
PMID:29191460
the dihydrolipoyl succinyltransferase (hE2o) and the dihydrolipoyl dehydrogenase (hE3) components of the tricarboxylic acid cycle 2-oxoglutarate dehydrogenase complex (OGDHc) for its activity
GO:0005739 mitochondrion
IDA
PMID:23141294
A nonsense mutation in DHTKD1 causes Charcot-Marie-Tooth dis...
ACCEPT
Summary: IDA localizing DHTKD1 to the mitochondrion, from the study that established the DHTKD1-CMT2 link and reported subcellular localization.
Reason: Direct experimental evidence for mitochondrial localization (UniProt SUBCELLULAR LOCATION cites this paper); concordant with all other data.
Supporting Evidence:
PMID:23141294
implicating an important role for DHTKD1 in mitochondrial energy production and neurological development.
GO:0006091 generation of precursor metabolites and energy
IMP
PMID:23141294
A nonsense mutation in DHTKD1 causes Charcot-Marie-Tooth dis...
MARK AS OVER ANNOTATED
Summary: IMP from a DHTKD1-silencing study reporting decreased ATP and total NAD(+)/NADH. This is a downstream physiological consequence of losing a lysine-catabolic enzyme rather than a direct biological process of DHTKD1.
Reason: DHTKD1 knockdown reduces cellular ATP/NAD(H) (an indirect metabolic readout), but DHTKD1 is not part of primary energy-generating machinery such as the TCA cycle or oxidative phosphorylation; its direct role is the 2-oxoadipate step of amino-acid (lysine/tryptophan) catabolism. This term over-generalizes a secondary phenotype. Note this contrasts with the OGDH paralog, which is a bona fide TCA-cycle energy enzyme. Retained (not removed) as it derives from an experimental IMP.
Supporting Evidence:
PMID:23141294
DHTKD1 silencing was found to lead to impaired energy production, evidenced by decreased ATP, total NAD(+) and NADH, and NADH levels
GO:0006569 L-tryptophan catabolic process
IEA
PMID:29191460
The mitochondrial 2-oxoadipate and 2-oxoglutarate dehydrogen...
NEW
Summary: Proposed additional biological-process annotation. 2-oxoadipate is the convergent intermediate of L-lysine, L-hydroxylysine AND L-tryptophan catabolism; by decarboxylating 2-oxoadipate, DHTKD1 catalyzes the final common step of the tryptophan degradation pathway as well as the lysine pathway.
Reason: UniProt explicitly states DHTKD1 is responsible for the last step of L-lysine, L-hydroxylysine and L-tryptophan catabolism (common product 2-oxoadipate). The tryptophan-catabolic role is not otherwise captured in GOA and complements the existing L-lysine catabolic process annotation.
Supporting Evidence:
PMID:29191460
It is involved in the oxidative decarboxylation of 2-oxoadipate (OA) to glutaryl-CoA on the final degradative pathway of L-lysine

Core Functions

Thiamine diphosphate-dependent 2-oxoadipate dehydrogenase (E1a) activity: the first, rate-limiting oxidative decarboxylation step of the mitochondrial 2-oxoadipate dehydrogenase complex, acting on the L-lysine/L-hydroxylysine/ L-tryptophan catabolic pathway.

Supporting Evidence:
  • PMID:29191460
    It is involved in the oxidative decarboxylation of 2-oxoadipate (OA) to glutaryl-CoA on the final degradative pathway of L-lysine
  • PMID:29191460
    hE1a displays an approximately 49-fold preference in catalytic efficiency for OA over OG, indicating that hE1a is specific to the 2-oxoadipate dehydrogenase complex

Thiamine diphosphate cofactor binding required for the decarboxylase activity of the E1a subunit.

Cellular Locations:
Supporting Evidence:
  • PMID:29191460
    Herein are reported unique properties of the novel human thiamin diphosphate (ThDP)-dependent enzyme 2-oxoadipate dehydrogenase (hE1a)

References

Gene Ontology annotation through association of InterPro records with GO terms
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
Gene Ontology annotation based on curation of immunofluorescence data
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Automatic Gene Ontology annotation based on Rhea mapping
Combined Automated Annotation using Multiple IEA Methods
A nonsense mutation in DHTKD1 causes Charcot-Marie-Tooth disease type 2 in a large Chinese pedigree.
Architecture of the human interactome defines protein communities and disease networks.
The mitochondrial 2-oxoadipate and 2-oxoglutarate dehydrogenase complexes share their E2 and E3 components for their function and both generate reactive oxygen species.
A reference map of the human binary protein interactome.
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.
Reactome:R-HSA-9858321
DHTKD1 dimer decarboxylates 2-OA
Reactome:R-HSA-9858589
DLD dimer dehydrogenates dihydrolipoyl
Reactome:R-HSA-9858590
DLST transfers glutaryl to CoA

Suggested Questions for Experts

Q: Given that DHTKD1 shares E2 (DLST) and E3 (DLD) with the 2-oxoglutarate dehydrogenase complex, how is flux partitioned between the OGDHC and OADHC in tissues where both are expressed (e.g. liver)?

Q: Why is alpha-aminoadipic/alpha-ketoadipic aciduria caused by DHTKD1 loss so frequently asymptomatic, and what genetic or metabolic factors modify the CMT2Q neuropathy phenotype?

Suggested Experiments

Experiment: Tissue-resolved metabolic flux analysis (e.g. 13C-lysine tracing) in DHTKD1-knockout versus wild-type cells to quantify the contribution of DHTKD1 to 2-oxoadipate turnover and downstream glutaryl-CoA and energy metabolism.

Hypothesis: DHTKD1 loss diverts 2-oxoadipate away from glutaryl-CoA, causing measurable accumulation of 2-oxoadipate/2-aminoadipate without major bioenergetic deficit.

Experiment: Structural and kinetic characterization of the assembled DHTKD1-DLST-DLD megacomplex to define substrate channeling and the effect of AAKAD variants (e.g. G729R, R715C) on complex assembly and activity.

Hypothesis: AAKAD-causing variants impair DHTKD1-DLST assembly, disrupting intermediate channeling rather than abolishing intrinsic decarboxylase chemistry.

📚 Additional Documentation

Notes

(DHTKD1-notes.md)

DHTKD1 review notes

Deep research status

just deep-research-falcon human Q96HY7 --alias DHTKD1 failed in this environment:
scripts/deep_research_wrapper.py uses X | None type-union syntax that raises
TypeError: unsupported operand type(s) for | under the interpreter available here
(recipe fails on line 218). The OLS MCP also errored (No module named 'rich.traceback').
No -deep-research-*.md file was fabricated. Review is grounded in the UniProt record
(DHTKD1-uniprot.txt), the seeded GOA, and cached publications/PMID_*.md. GO term
labels/aspects/obsolescence were verified directly against the QuickGO REST API.

Verified biology (from UniProt Q96HY7 + PMID:29191460)

  • DHTKD1 = 2-oxoadipate dehydrogenase complex component E1 (E1a / OADH-E1), a
    thiamine-diphosphate (ThDP)-dependent enzyme; paralog of OGDH (E1o).
    [UniProt: "2-oxoadipate dehydrogenase (E1a) component of the 2-oxoadipate
    dehydrogenase complex (OADHC)"]
  • Catalyzes the irreversible oxidative decarboxylation of 2-oxoadipate (alpha-
    ketoadipate)
    to a glutaryl intermediate that is transferred to the lipoyl group of
    the shared E2 (DLST); overall complex product is glutaryl-CoA + CO2. First / rate-
    limiting step of OADHC. RHEA:69576. [UniProt CATALYTIC ACTIVITY]
  • Rate-limiting last step of L-lysine, L-hydroxylysine and L-tryptophan catabolism,
    whose common intermediate is 2-oxoadipate. [UniProt FUNCTION]
  • Shares E2 (DLST) and E3 (DLD) with the TCA-cycle 2-oxoglutarate dehydrogenase complex;
    E1 component is complex-specific. Can decarboxylate 2-oxoglutarate in vitro but ~49x
    prefers 2-oxoadipate. [PMID:29191460 abstract]
  • Functional unit is a homodimer; interacts with DLST. [UniProt SUBUNIT; PMID:32695416]
  • Cofactor: thiamine diphosphate. [UniProt COFACTOR; PMID:32695416]
  • Localization: mitochondrion / mitochondrial matrix. [UniProt SUBCELLULAR LOCATION,
    PMID:23141294; Reactome]
  • Disease: alpha-aminoadipic/alpha-ketoadipic aciduria (AAKAD) (often asymptomatic)
    and Charcot-Marie-Tooth disease axonal type 2Q (CMT2Q). [UniProt DISEASE]

Annotation-by-annotation reasoning

  • MF GO:0160166 2-oxoadipate dehydrogenase activity — IDA (PMID:29191460) + RHEA IEA:
    ACCEPT both; this is the core catalytic activity.
  • MF GO:0016624 (oxidoreductase, aldehyde/oxo donor, disulfide acceptor) IEA: parent of
    the full E1+E2+E3 disulfide-acceptor reaction; DHTKD1 alone does the ThDP decarboxylation
    and transfers to the E2 lipoyl group (not disulfide). This is a broad InterPro-family
    term that better describes the complex than E1a in isolation → MARK_AS_OVER_ANNOTATED
    (not wrong at family level, but imprecise for the E1 subunit; GO:0160166 is the precise term).
  • MF GO:0030976 thiamine pyrophosphate binding IEA: ACCEPT — ThDP is the cofactor
    (UniProt COFACTOR, crystal structure PMID:32633484/32695416).
  • The three GO:0005515 protein binding IPIs are from high-throughput interactome
    screens (BioPlex, HuRI/binary Y2H, BioPlex-derived). Per policy: bare protein binding
    IPIs → MARK_AS_OVER_ANNOTATED (uninformative; the biologically meaningful partner is
    DLST/E2, captured by the complex-membership term).
  • CC mitochondrion/matrix (several IEA/IDA/HTP/TAS): ACCEPT the experimental matrix ones;
    the generic mitochondrion calls are correct but less precise than mitochondrial matrix.
  • CC GO:0160167 oxoadipate dehydrogenase complex IDA (PMID:29191460): ACCEPT — core.
  • BP GO:0019477 L-lysine catabolic process IEA: ACCEPT (core pathway).
  • BP GO:0009063 amino acid catabolic process IEA: correct but generic parent →
    KEEP_AS_NON_CORE.
  • BP GO:0006091 generation of precursor metabolites and energy IMP (PMID:23141294):
    the paper shows DHTKD1 silencing impairs ATP/NAD(H); this is a downstream/indirect
    physiological readout, not the gene's direct process → MARK_AS_OVER_ANNOTATED.

📄 View Raw YAML

id: Q96HY7
gene_symbol: DHTKD1
product_type: PROTEIN
status: INITIALIZED
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  DHTKD1 is the E1 component (E1a; 2-oxoadipate dehydrogenase, OADH-E1) of the
  mitochondrial 2-oxoadipate dehydrogenase complex (OADHC). It is a thiamine
  diphosphate (ThDP)-dependent decarboxylase and a paralog of OGDH, the
  2-oxoglutarate dehydrogenase E1. DHTKD1 catalyzes the first, rate-limiting and
  irreversible step of the complex: the oxidative decarboxylation of 2-oxoadipate
  (alpha-ketoadipate), transferring the decarboxylated glutaryl intermediate onto
  the lipoyl group of the shared E2 subunit (DLST), with the overall complex
  producing glutaryl-CoA and CO2. OADHC uses the same E2 (DLST) and E3 (DLD)
  components as the TCA-cycle 2-oxoglutarate dehydrogenase complex, but the E1
  subunit is complex-specific; DHTKD1 strongly prefers 2-oxoadipate over
  2-oxoglutarate as substrate. This reaction is the final common step of L-lysine,
  L-hydroxylysine and L-tryptophan degradation, whose convergent intermediate is
  2-oxoadipate. The enzyme functions as a homodimer in the mitochondrial matrix.
  Loss-of-function variants cause alpha-aminoadipic and alpha-ketoadipic aciduria
  (AAKAD, frequently benign), and DHTKD1 has also been linked to axonal
  Charcot-Marie-Tooth disease type 2Q.
existing_annotations:
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  qualifier: located_in
  review:
    summary: >-
      Subcellular-location IEA placing DHTKD1 in the mitochondrion, consistent
      with all experimental evidence and the mitochondrial transit peptide.
      Correct but less precise than the mitochondrial matrix localization
      supported by Reactome/Ensembl orthology.
    action: ACCEPT
    reason: >-
      DHTKD1 is a validated mitochondrial matrix enzyme (UniProt SUBCELLULAR
      LOCATION, PMID:23141294). The generic mitochondrion term is correct.
    supported_by:
    - reference_id: PMID:23141294
      supporting_text: >-
        implicating an important role for DHTKD1 in mitochondrial energy
        production and neurological development.
- term:
    id: GO:0016624
    label: oxidoreductase activity, acting on the aldehyde or oxo group of donors,
      disulfide as acceptor
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      Broad InterPro/orthology-based oxidoreductase term describing the
      overall E1+E2+E3 (disulfide-acceptor) chemistry of the 2-oxo-acid
      dehydrogenase family. The precise activity of the E1a subunit is the
      ThDP-dependent decarboxylation captured by GO:0160166.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      This family-level term describes the full dehydrogenase complex reaction
      in which the ultimate electron acceptor is a disulfide (lipoyl/E3). The
      DHTKD1 E1a subunit itself performs ThDP-dependent decarboxylation of
      2-oxoadipate and transfers the acyl group to the E2 lipoyl moiety; the
      more specific and accurate MF for DHTKD1 is GO:0160166 (2-oxoadipate
      dehydrogenase activity), which is separately annotated with IDA support.
    supported_by:
    - reference_id: PMID:29191460
      supporting_text: >-
        It is involved in the oxidative decarboxylation of 2-oxoadipate (OA) to
        glutaryl-CoA on the final degradative pathway of L-lysine
- term:
    id: GO:0030976
    label: thiamine pyrophosphate binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: >-
      InterPro-based annotation of thiamine diphosphate (ThDP) binding. ThDP is
      the essential catalytic cofactor of DHTKD1, confirmed biochemically and by
      crystal structures of the DHTKD1-ThDP complex.
    action: ACCEPT
    reason: >-
      DHTKD1 is a ThDP-dependent decarboxylase; ThDP is documented as its
      cofactor (UniProt COFACTOR, PMID:32695416; DHTKD1-ThDP crystal structure
      PMID:32633484). The InterPro TPP-binding domain (IPR011603/IPR029061) is
      present. This is a core molecular function.
    supported_by:
    - reference_id: PMID:29191460
      supporting_text: >-
        Herein are reported unique properties of the novel human thiamin
        diphosphate (ThDP)-dependent enzyme 2-oxoadipate dehydrogenase (hE1a)
- term:
    id: GO:0160166
    label: 2-oxoadipate dehydrogenase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000116
  qualifier: enables
  review:
    summary: >-
      RHEA-mapped IEA for the core catalytic activity of DHTKD1: the
      ThDP-dependent oxidative decarboxylation of 2-oxoadipate (RHEA:69576).
      This is the primary, experimentally validated molecular function.
    action: ACCEPT
    reason: >-
      Matches the reaction assigned in UniProt (RHEA:69576) and is directly
      supported by biochemistry (PMID:29191460, PMID:32633484) and structure.
      Duplicate of the IDA-supported GO:0160166 below; both are correct.
    supported_by:
    - reference_id: PMID:29191460
      supporting_text: >-
        hE1a displays an approximately 49-fold preference in catalytic
        efficiency for OA over OG, indicating that hE1a is specific to the
        2-oxoadipate dehydrogenase complex
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:28514442
  qualifier: enables
  review:
    summary: >-
      High-throughput affinity-purification/mass-spectrometry interactome
      (BioPlex 2.0) IPI to PGLYRP3 (Q96LB9). Bare "protein binding" is
      uninformative about DHTKD1's molecular function.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      This is a proteome-scale AP-MS screen, not a directed study of DHTKD1's
      biology; the recorded partner (PGLYRP3) has no established functional
      relationship to 2-oxoadipate catabolism. Per curation guidance, bare
      GO:0005515 protein binding IPIs are uninformative and are marked as
      over-annotation rather than removed. The biologically meaningful
      interaction of DHTKD1 is with the E2 subunit DLST, captured by the
      oxoadipate dehydrogenase complex annotation.
    supported_by:
    - reference_id: PMID:28514442
      supporting_text: >-
        BioPlex 2.0 exceeds previous experimentally derived interaction networks
        in depth and breadth
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32296183
  qualifier: enables
  review:
    summary: >-
      Binary yeast-two-hybrid interactome (HuRI) IPI to an isoform of BMAL1
      (O00327-8). Bare "protein binding" is uninformative about DHTKD1's
      molecular function.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      This is a genome-scale binary interaction map, not a directed functional
      study of DHTKD1. The reported partner has no established role in
      2-oxoadipate/lysine catabolism. Per curation guidance, bare protein
      binding IPIs are marked as over-annotation rather than removed.
    supported_by:
    - reference_id: PMID:32296183
      supporting_text: A reference map of the human binary protein interactome.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:33961781
  qualifier: enables
  review:
    summary: >-
      High-throughput AP-MS interactome (BioPlex-derived, cell-specific
      networks) IPI to PGLYRP3 (Q96LB9). Bare "protein binding" is
      uninformative about DHTKD1's molecular function.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Proteome-scale interactome dataset rather than a directed DHTKD1 study;
      the reported partner has no established connection to 2-oxoadipate
      catabolism. Per curation guidance, bare protein binding IPIs are marked
      as over-annotation rather than removed.
    supported_by:
    - reference_id: PMID:33961781
      supporting_text: Dual proteome-scale networks reveal cell-specific remodeling
        of the human interactome.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: is_active_in
  review:
    summary: >-
      Orthology-based (Ensembl Compara) is_active_in annotation to the
      mitochondrial matrix, transferred from mouse ortholog. Consistent with
      the matrix localization of a soluble ThDP-dependent dehydrogenase.
    action: ACCEPT
    reason: >-
      DHTKD1 has an N-terminal mitochondrial transit peptide and functions as a
      soluble matrix enzyme of the OADHC; matrix localization is supported by
      Reactome and by the shared architecture with the OGDH complex.
    supported_by:
    - reference_id: PMID:29191460
      supporting_text: >-
        the dihydrolipoyl succinyltransferase (hE2o) and the dihydrolipoyl
        dehydrogenase (hE3) components of the tricarboxylic acid cycle
        2-oxoglutarate dehydrogenase complex (OGDHc) for its activity
- term:
    id: GO:0009063
    label: amino acid catabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: >-
      Orthology-based involvement in amino acid catabolism. Correct but a
      generic parent of the specific L-lysine/L-tryptophan catabolic processes
      DHTKD1 participates in.
    action: KEEP_AS_NON_CORE
    reason: >-
      Accurate at a high level (DHTKD1 acts on the convergent 2-oxoadipate step
      of lysine/hydroxylysine/tryptophan degradation) but subsumed by the more
      specific L-lysine catabolic process (GO:0019477). Retained as non-core
      background rather than as a distinct core function.
    supported_by:
    - reference_id: PMID:29191460
      supporting_text: >-
        on the final degradative pathway of L-lysine and is critical for
        mitochondrial metabolism
- term:
    id: GO:0019477
    label: L-lysine catabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: >-
      Orthology-based annotation to L-lysine catabolism. This is the principal
      biological process in which DHTKD1 acts, catalyzing the final common
      2-oxoadipate step of the lysine (and hydroxylysine/tryptophan)
      degradation pathway.
    action: ACCEPT
    reason: >-
      Well supported: DHTKD1 performs the rate-limiting decarboxylation of
      2-oxoadipate, the convergent intermediate of L-lysine catabolism; disease
      variants cause elevated 2-oxoadipate/2-aminoadipate. Core process.
    supported_by:
    - reference_id: PMID:29191460
      supporting_text: >-
        It is involved in the oxidative decarboxylation of 2-oxoadipate (OA) to
        glutaryl-CoA on the final degradative pathway of L-lysine
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IDA
  original_reference_id: GO_REF:0000052
  qualifier: located_in
  review:
    summary: >-
      Immunofluorescence-based (HPA) IDA localizing DHTKD1 to the
      mitochondrion. Consistent with all other evidence.
    action: ACCEPT
    reason: >-
      Directly observed mitochondrial localization by immunofluorescence,
      concordant with the mitochondrial matrix function of the OADHC E1a
      subunit.
    supported_by:
    - reference_id: PMID:23141294
      supporting_text: >-
        implicating an important role for DHTKD1 in mitochondrial energy
        production and neurological development.
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: HTP
  original_reference_id: PMID:34800366
  qualifier: located_in
  review:
    summary: >-
      High-throughput mitochondrial proteomics (MitoCoP) detecting DHTKD1 in
      the high-confidence human mitochondrial proteome.
    action: ACCEPT
    reason: >-
      Independent proteomic confirmation of mitochondrial localization,
      consistent with the transit peptide and matrix function.
    supported_by:
    - reference_id: PMID:34800366
      supporting_text: >-
        defined a mitochondrial high-confidence proteome of >1,100 proteins
        (MitoCoP)
- term:
    id: GO:0160166
    label: 2-oxoadipate dehydrogenase activity
  evidence_type: IDA
  original_reference_id: PMID:29191460
  qualifier: enables
  review:
    summary: >-
      Direct biochemical demonstration that recombinant human E1a (DHTKD1)
      oxidatively decarboxylates 2-oxoadipate, with ~49-fold catalytic
      preference for 2-oxoadipate over 2-oxoglutarate. This is the defining,
      experimentally validated molecular function of the gene.
    action: ACCEPT
    reason: >-
      Gold-standard IDA evidence for the core catalytic activity; corroborated
      by kinetics (KM 0.012-0.015 mM for 2-oxoadipate) and crystal structures
      (PMID:32633484, PMID:32695416).
    supported_by:
    - reference_id: PMID:29191460
      supporting_text: >-
        hE1a displays an approximately 49-fold preference in catalytic
        efficiency for OA over OG, indicating that hE1a is specific to the
        2-oxoadipate dehydrogenase complex
- term:
    id: GO:0160167
    label: oxoadipate dehydrogenase complex
  evidence_type: IDA
  original_reference_id: PMID:29191460
  qualifier: part_of
  review:
    summary: >-
      DHTKD1 is the E1a subunit of the 2-oxoadipate dehydrogenase complex,
      which it forms together with the shared E2 (DLST) and E3 (DLD) components
      of the 2-oxoglutarate dehydrogenase machinery. Directly demonstrated by
      reconstitution of an active complex.
    action: ACCEPT
    reason: >-
      Core cellular-component annotation. DHTKD1 recruits E2 (DLST) and E3 (DLD)
      to assemble a functional OADHC; the E1 subunit is complex-specific. This
      is the biologically meaningful protein-protein assembly for DHTKD1.
    supported_by:
    - reference_id: PMID:29191460
      supporting_text: >-
        The hE1a has recruited the dihydrolipoyl succinyltransferase (hE2o) and
        the dihydrolipoyl dehydrogenase (hE3) components of the tricarboxylic
        acid cycle 2-oxoglutarate dehydrogenase complex (OGDHc) for its activity
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9858321
  qualifier: located_in
  review:
    summary: >-
      Reactome TAS localizing the DHTKD1-catalyzed 2-oxoadipate decarboxylation
      to the mitochondrial matrix, the compartment of the OADHC.
    action: ACCEPT
    reason: >-
      Consistent with the soluble matrix location of the E1a subunit of the
      OADHC and with orthology/proteomic evidence.
    supported_by:
    - reference_id: PMID:29191460
      supporting_text: >-
        the tricarboxylic acid cycle 2-oxoglutarate dehydrogenase complex
        (OGDHc) for its activity
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9858589
  qualifier: located_in
  review:
    summary: >-
      Reactome TAS localizing the OADHC E3 (DLD) dihydrolipoyl dehydrogenation
      step to the mitochondrial matrix, the compartment where DHTKD1 acts.
    action: ACCEPT
    reason: >-
      Matrix localization is well established for the OADHC in which DHTKD1 is
      the E1 subunit.
    supported_by:
    - reference_id: PMID:29191460
      supporting_text: >-
        the dihydrolipoyl dehydrogenase (hE3) components of the tricarboxylic
        acid cycle 2-oxoglutarate dehydrogenase complex (OGDHc) for its activity
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9858590
  qualifier: located_in
  review:
    summary: >-
      Reactome TAS localizing the OADHC E2 (DLST) glutaryl transfer to CoA in
      the mitochondrial matrix, the compartment where DHTKD1 acts.
    action: ACCEPT
    reason: >-
      Consistent with matrix localization of the OADHC and of DHTKD1.
    supported_by:
    - reference_id: PMID:29191460
      supporting_text: >-
        the dihydrolipoyl succinyltransferase (hE2o) and the dihydrolipoyl
        dehydrogenase (hE3) components of the tricarboxylic acid cycle
        2-oxoglutarate dehydrogenase complex (OGDHc) for its activity
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IDA
  original_reference_id: PMID:23141294
  qualifier: located_in
  review:
    summary: >-
      IDA localizing DHTKD1 to the mitochondrion, from the study that
      established the DHTKD1-CMT2 link and reported subcellular localization.
    action: ACCEPT
    reason: >-
      Direct experimental evidence for mitochondrial localization (UniProt
      SUBCELLULAR LOCATION cites this paper); concordant with all other data.
    supported_by:
    - reference_id: PMID:23141294
      supporting_text: >-
        implicating an important role for DHTKD1 in mitochondrial energy
        production and neurological development.
- term:
    id: GO:0006091
    label: generation of precursor metabolites and energy
  evidence_type: IMP
  original_reference_id: PMID:23141294
  qualifier: involved_in
  review:
    summary: >-
      IMP from a DHTKD1-silencing study reporting decreased ATP and total
      NAD(+)/NADH. This is a downstream physiological consequence of losing a
      lysine-catabolic enzyme rather than a direct biological process of DHTKD1.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      DHTKD1 knockdown reduces cellular ATP/NAD(H) (an indirect metabolic
      readout), but DHTKD1 is not part of primary energy-generating machinery
      such as the TCA cycle or oxidative phosphorylation; its direct role is the
      2-oxoadipate step of amino-acid (lysine/tryptophan) catabolism. This term
      over-generalizes a secondary phenotype. Note this contrasts with the OGDH
      paralog, which is a bona fide TCA-cycle energy enzyme. Retained (not
      removed) as it derives from an experimental IMP.
    supported_by:
    - reference_id: PMID:23141294
      supporting_text: >-
        DHTKD1 silencing was found to lead to impaired energy production,
        evidenced by decreased ATP, total NAD(+) and NADH, and NADH levels
- term:
    id: GO:0006569
    label: L-tryptophan catabolic process
  evidence_type: IEA
  original_reference_id: PMID:29191460
  qualifier: involved_in
  review:
    summary: >-
      Proposed additional biological-process annotation. 2-oxoadipate is the
      convergent intermediate of L-lysine, L-hydroxylysine AND L-tryptophan
      catabolism; by decarboxylating 2-oxoadipate, DHTKD1 catalyzes the final
      common step of the tryptophan degradation pathway as well as the lysine
      pathway.
    action: NEW
    reason: >-
      UniProt explicitly states DHTKD1 is responsible for the last step of
      L-lysine, L-hydroxylysine and L-tryptophan catabolism (common product
      2-oxoadipate). The tryptophan-catabolic role is not otherwise captured in
      GOA and complements the existing L-lysine catabolic process annotation.
    supported_by:
    - reference_id: PMID:29191460
      supporting_text: >-
        It is involved in the oxidative decarboxylation of 2-oxoadipate (OA) to
        glutaryl-CoA on the final degradative pathway of L-lysine
core_functions:
- description: >-
    Thiamine diphosphate-dependent 2-oxoadipate dehydrogenase (E1a) activity: the
    first, rate-limiting oxidative decarboxylation step of the mitochondrial
    2-oxoadipate dehydrogenase complex, acting on the L-lysine/L-hydroxylysine/
    L-tryptophan catabolic pathway.
  molecular_function:
    id: GO:0160166
    label: 2-oxoadipate dehydrogenase activity
  directly_involved_in:
  - id: GO:0019477
    label: L-lysine catabolic process
  - id: GO:0006569
    label: L-tryptophan catabolic process
  locations:
  - id: GO:0005759
    label: mitochondrial matrix
  in_complex:
    id: GO:0160167
    label: oxoadipate dehydrogenase complex
  supported_by:
  - reference_id: PMID:29191460
    supporting_text: >-
      It is involved in the oxidative decarboxylation of 2-oxoadipate (OA) to
      glutaryl-CoA on the final degradative pathway of L-lysine
  - reference_id: PMID:29191460
    supporting_text: >-
      hE1a displays an approximately 49-fold preference in catalytic efficiency
      for OA over OG, indicating that hE1a is specific to the 2-oxoadipate
      dehydrogenase complex
- description: >-
    Thiamine diphosphate cofactor binding required for the decarboxylase activity
    of the E1a subunit.
  molecular_function:
    id: GO:0030976
    label: thiamine pyrophosphate binding
  locations:
  - id: GO:0005759
    label: mitochondrial matrix
  supported_by:
  - reference_id: PMID:29191460
    supporting_text: >-
      Herein are reported unique properties of the novel human thiamin
      diphosphate (ThDP)-dependent enzyme 2-oxoadipate dehydrogenase (hE1a)
proposed_new_terms: []
suggested_questions:
- question: >-
    Given that DHTKD1 shares E2 (DLST) and E3 (DLD) with the 2-oxoglutarate
    dehydrogenase complex, how is flux partitioned between the OGDHC and OADHC in
    tissues where both are expressed (e.g. liver)?
- question: >-
    Why is alpha-aminoadipic/alpha-ketoadipic aciduria caused by DHTKD1 loss so
    frequently asymptomatic, and what genetic or metabolic factors modify the
    CMT2Q neuropathy phenotype?
suggested_experiments:
- description: >-
    Tissue-resolved metabolic flux analysis (e.g. 13C-lysine tracing) in
    DHTKD1-knockout versus wild-type cells to quantify the contribution of DHTKD1
    to 2-oxoadipate turnover and downstream glutaryl-CoA and energy metabolism.
  hypothesis: >-
    DHTKD1 loss diverts 2-oxoadipate away from glutaryl-CoA, causing measurable
    accumulation of 2-oxoadipate/2-aminoadipate without major bioenergetic deficit.
- description: >-
    Structural and kinetic characterization of the assembled DHTKD1-DLST-DLD
    megacomplex to define substrate channeling and the effect of AAKAD variants
    (e.g. G729R, R715C) on complex assembly and activity.
  hypothesis: >-
    AAKAD-causing variants impair DHTKD1-DLST assembly, disrupting intermediate
    channeling rather than abolishing intrinsic decarboxylase chemistry.
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping, accompanied by conservative changes to GO terms applied by
    UniProt
  findings: []
- id: GO_REF:0000052
  title: Gene Ontology annotation based on curation of immunofluorescence data
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to
    orthologs using Ensembl Compara
  findings: []
- id: GO_REF:0000116
  title: Automatic Gene Ontology annotation based on Rhea mapping
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:23141294
  title: A nonsense mutation in DHTKD1 causes Charcot-Marie-Tooth disease type 2 in
    a large Chinese pedigree.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified. Establishes DHTKD1 loss-of-function in CMT2Q and reports
      mitochondrial localization and impaired ATP/NAD(H) on silencing. Cited
      correctly for the mitochondrion (IDA) and energy (IMP) annotations.
- id: PMID:28514442
  title: Architecture of the human interactome defines protein communities and disease
    networks.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      BioPlex 2.0 AP-MS interactome. Correctly cited as the source of a
      high-throughput protein-binding IPI, but not a directed study of DHTKD1
      function; the recorded partner is not functionally informative.
- id: PMID:29191460
  title: The mitochondrial 2-oxoadipate and 2-oxoglutarate dehydrogenase complexes
    share their E2 and E3 components for their function and both generate reactive
    oxygen species.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Primary biochemical characterization of human E1a (DHTKD1): ThDP-dependent
      2-oxoadipate decarboxylation, ~49x preference for 2-oxoadipate over
      2-oxoglutarate, and recruitment of shared E2/E3. Anchors the core MF and
      complex annotations.
- id: PMID:32296183
  title: A reference map of the human binary protein interactome.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      HuRI binary Y2H interactome. Source of a high-throughput protein-binding
      IPI; not a directed DHTKD1 study and functionally uninformative for this
      gene.
- id: PMID:33961781
  title: Dual proteome-scale networks reveal cell-specific remodeling of the human
    interactome.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      BioPlex-derived proteome-scale interactome. Source of a high-throughput
      protein-binding IPI; not functionally informative for DHTKD1.
- id: PMID:34800366
  title: Quantitative high-confidence human mitochondrial proteome and its dynamics
    in cellular context.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      MitoCoP high-confidence mitochondrial proteome; independently confirms
      DHTKD1 mitochondrial localization.
- id: Reactome:R-HSA-9858321
  title: DHTKD1 dimer decarboxylates 2-OA
  findings: []
- id: Reactome:R-HSA-9858589
  title: DLD dimer dehydrogenates dihydrolipoyl
  findings: []
- id: Reactome:R-HSA-9858590
  title: DLST transfers glutaryl to CoA
  findings: []